Back to RU Rubric Capital Management LP
STML
Showing 0 of 3 quarters
Position history for RURubric Capital Management LP's holdings in STEMLINE THERAPEUTICS INC
As of its Q1 2020 13F, Rubric Capital Management held 3,347,141 shares of STML (Stemline Therapeutics), worth $16.2M. Rubric Capital Management listed STML in 2 quarterly 13F filings through Q1 2020. STML was 2.6% of Rubric Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.